Titelia

Funds holding BELITE BIO INC

ISIN US07782B1044 · Cayman Islands · LEI 984500BD54036BOEAE79

Fund holders
22
Of which ETFs
7 15 other funds
Value held
30.6M $
FundSharesValueWeight in fund
T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. 80,46212.4M $0.10 %as of Jun 30, 2026 ↗
Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST 62,2059.6M $0.54 %as of Jun 30, 2026 ↗
State Street(R) SPDR(R) Portfolio Emerging Markets ETF SPDR INDEX SHARES FUNDS 12,4561.9M $0.01 %as of Jun 30, 2026 ↗
Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust 6,727969.9K $0.00 %as of May 31, 2026 ↗
Fidelity ZERO International Index Fund Fidelity Concord Street Trust 5,934941.2K $0.01 %as of Jul 31, 2026 ↗
T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. 5,400831.5K $0.11 %as of Jun 30, 2026 ↗
Fidelity Nasdaq Composite Index ETF Fidelity Commonwealth Trust 3,734538.4K $0.00 %as of May 31, 2026 ↗
ActivePassive International Equity ETF Trust for Professional Managers 3,713535.3K $0.05 %as of May 31, 2026 ↗
Select Biotechnology Portfolio Fidelity Select Portfolios 3,100447K $0.01 %as of May 31, 2026 ↗
State Street(R) SPDR(R) S&P(R) China ETF SPDR INDEX SHARES FUNDS 3,068472.4K $0.11 %as of Jun 30, 2026 ↗
Virtus Biotech Clinical Trials Etf ETFis Series Trust I 2,250356.9K $0.77 %as of Jul 31, 2026 ↗
Fidelity Flex International Index Fund Fidelity Salem Street Trust 2,090331.5K $0.01 %as of Jul 31, 2026 ↗
Health Sciences Trust John Hancock Variable Insurance Trust 1,800277.2K $0.11 %as of Jun 30, 2026 ↗
EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust 1,400215.6K $0.12 %as of Jun 30, 2026 ↗
Even Herd Long Short ETF Tidal Trust II 1,282197.4K $0.33 %as of Jun 30, 2026 ↗
ULTRACHINA PROFUND ProFunds 1,030163.4K $0.80 %as of Jul 31, 2026 ↗
Parametric Tax-Managed Emerging Markets Fund Eaton Vance Series Trust II 781120.3K $0.02 %as of Jun 30, 2026 ↗
VIP International Index Portfolio Variable Insurance Products Fund II 64198.7K $0.01 %as of Jun 30, 2026 ↗
ALGER SMALL CAP GROWTH FUND ALGER FUNDS 62999.8K $0.05 %as of Jul 31, 2026 ↗
Alger Small Cap Growth Portfolio ALGER PORTFOLIOS 48975.3K $0.05 %as of Jun 30, 2026 ↗
ALGER SMALL CAP GROWTH INSTITUTIONAL FUND ALGER INSTITUTIONAL FUNDS 24839.3K $0.05 %as of Jul 31, 2026 ↗
T. Rowe Price Innovation Leaders ETF T. Rowe Price Exchange-Traded Funds, Inc. 10215.7K $0.09 %as of Jun 30, 2026 ↗

Download this table: CSV, JSON

Report an error

The funds most exposed to it

The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.

FundWeight in fund
ULTRACHINA PROFUND ProFunds 0.80 %as of Jul 31, 2026 ↗
Virtus Biotech Clinical Trials Etf ETFis Series Trust I 0.77 %as of Jul 31, 2026 ↗
Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST 0.54 %as of Jun 30, 2026 ↗
Even Herd Long Short ETF Tidal Trust II 0.33 %as of Jun 30, 2026 ↗
EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust 0.12 %as of Jun 30, 2026 ↗
T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. 0.11 %as of Jun 30, 2026 ↗
Health Sciences Trust John Hancock Variable Insurance Trust 0.11 %as of Jun 30, 2026 ↗
State Street(R) SPDR(R) S&P(R) China ETF SPDR INDEX SHARES FUNDS 0.11 %as of Jun 30, 2026 ↗
T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. 0.10 %as of Jun 30, 2026 ↗
T. Rowe Price Innovation Leaders ETF T. Rowe Price Exchange-Traded Funds, Inc. 0.09 %as of Jun 30, 2026 ↗

Quarter after quarter

Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.

QuarterHoldersChangeSharesChange
2026Q322-3199,541-48.9 %
2026Q225+11390,785+150.3 %
2026Q114+7156,142+432.0 %
2025Q47-229,348-17.4 %
2025Q39+135,531+2.0 %
2025Q28-234,820+9.7 %
2025Q110+231,731+2.0 %
2024Q48031,113+20.3 %
2024Q38+225,854+0.4 %
2024Q26+125,742-0.8 %
2024Q15-125,961+2.6 %
2023Q4625,305

Institutional managers

75 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.

ManagerSharesValue
Darwin Global Management, Ltd.3,057,412456.1M $as of Mar 31, 2026
Paradigm Biocapital Advisors LP1,114,784177.7M $as of Mar 31, 2026
UBS Group AG768,359122.5M $as of Mar 31, 2026
RTW INVESTMENTS, LP715,332114.1M $as of Mar 31, 2026
MILLENNIUM MANAGEMENT LLC570,08890.9M $as of Mar 31, 2026
Holocene Advisors, LP494,49578.8M $as of Mar 31, 2026
EVENTIDE ASSET MANAGEMENT, LLC357,65057M $as of Mar 31, 2026
DEERFIELD MANAGEMENT COMPANY, L.P.304,01348.5M $as of Mar 31, 2026
PRICE T ROWE ASSOCIATES INC /MD/281,80544.9K $as of Mar 31, 2026
MORGAN STANLEY201,40932.1M $as of Mar 31, 2026
PERCEPTIVE ADVISORS LLC151,97924.2M $as of Mar 31, 2026
Patient Square Capital LP116,68418.6M $as of Mar 31, 2026
Duquesne Family Office LLC106,10016.9K $as of Mar 31, 2026
GOLDMAN SACHS GROUP INC105,50916.8M $as of Mar 31, 2026
MPM BIOIMPACT LLC88,04514M $as of Mar 31, 2026
Affinity Asset Advisors, LLC65,00010.4M $as of Mar 31, 2026
FRED ALGER MANAGEMENT, LLC62,57410M $as of Mar 31, 2026
PFM Health Sciences, LP59,4329.5M $as of Mar 31, 2026
RENAISSANCE TECHNOLOGIES LLC52,0008.3M $as of Mar 31, 2026
Longaeva Partners L.P.33,4925.3M $as of Mar 31, 2026
TD Asset Management Inc33,4105.3M $as of Mar 31, 2026
BNP PARIBAS FINANCIAL MARKETS32,5255.2M $as of Mar 31, 2026
ADAR1 Capital Management, LLC26,8804.3M $as of Mar 31, 2026
Artia Global Partners LP24,9894M $as of Mar 31, 2026
Quadrature Capital Ltd23,7083.8M $as of Mar 31, 2026
Cite this page

Titelia. "Funds holding BELITE BIO INC". https://titelia.com/en/stocks/belite-bio-inc-US07782B1044